WallStreetZenWallStreetZen

NASDAQ: ARQT
Arcutis Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Arcutis Biotherapeutics earnings were -$16.1M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest ARQT earnings report on Dec 31, 2025 announced Q4 2025 earnings of $17.4M, up 134.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ARQT reported annual earnings of -$16.1M, with -88.5% growth.

ARQT earnings history

Current Revenue
$376.1M
Current Earnings
-$16.1M
Current Profit Margin
-4.3%

ARQT Return on Equity

Current Company
-10.3%
Current Industry
-8.4%
Current Market
29.9%
ARQT's Return on Equity (-10.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ARQT Return on Assets

Current Company
-4.3%
Current Industry
-5.7%
ARQT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ARQT announces earnings.

ARQT Return on Capital Employed

Current Company
-0.95%
Current Industry
0.2%
ARQT has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARQT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ARQT$1.78M-$16.14MN/A-$0.13
IDYA-$109.11M-$113.70MN/A-$1.28
CPRX$321.68M$214.33M+19.44%$1.75
RCUS-$328.00M-$353.00MN/A-$3.29
TARS-$52.93M-$66.42MN/A-$1.59
View Top Biotech Stocks

Arcutis Biotherapeutics Earnings Reports & History FAQ

What were Arcutis Biotherapeutics's earnings last quarter?

Arcutis Biotherapeutics (NASDAQ: ARQT) reported Q4 2025 earnings per share (EPS) of $0.13, up 262.5% year over year. Total ARQT earnings for the quarter were $17.40 million. In the same quarter last year, Arcutis Biotherapeutics's earnings per share (EPS) was -$0.08.

If you're new to stock investing, here's how to buy Arcutis Biotherapeutics stock.

Is Arcutis Biotherapeutics profitable or losing money?

As of the last Arcutis Biotherapeutics earnings report, Arcutis Biotherapeutics is currently losing money. Arcutis Biotherapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$16.14 million, a 88.47% decrease year over year.

What was ARQT's earnings growth in the past year?

As of Arcutis Biotherapeutics's earnings date in Q1 2026, Arcutis Biotherapeutics's earnings has grown year over year. ARQT earnings in the past year totalled -$16.14 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.